Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;14(5):570-576.
doi: 10.1016/j.jiph.2021.02.001. Epub 2021 Feb 9.

Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy

Marie Chedid  1 , Rami Waked  2 , Elie Haddad  1 , Nabil Chetata  1 , Gebrael Saliba  1 , Jacques Choucair  1
Affiliations
Review

Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy

Marie Chedid et al. J Infect Public Health. 2021 May.

Abstract

Objectives: To report available information in the literature regarding frequency, indications, types of antibiotic usage, duration, and their efficacy in Covid-19 infected patients.

Methods: The search was conducted on April 30 and May 7, 2020, using Ovid database and Google search. Patients' characteristics, clinical outcomes, as well as selected characteristics regarding antibiotic use (indication, class used, rates and types of bacterial secondary and co-infection, and duration of treatment) were analyzed.

Results: Nineteen clinical studies reporting data from 2834 patients were included. Mean rate of antibiotic use was 74.0 % of cases. Half the studies reported occurrence of a bacterial co-infection or complication (10 studies). Amongst the latter, at least 17.6 % of patients who received antibiotics had secondary infections. Pooled data of 4 studies show that half of patients receiving antibiotics were not severe nor critical. Detailed data on antibiotic use lack in most articles.

Conclusions: The present review found a major use of antibiotics amongst Covid-19 hospitalized patients, mainly in an empirical setting. There is no proven efficacy of this practice. Further research to determine relevant indications for antibiotic use in Covid-19 patients is critical in view of the significant mortality associated with secondary infections in these patients, and the rising antimicrobial resistance.

Keywords: Antibiotic treatment; COVID-19; Coronavirus infection; Pneumonia; Review paper.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of the search.
See this image and copyright information in PMC

References

    1. IACG_final_report_EN.pdf [Internet]. [cited 2020 May 18]. Available from: https://www.who.int/antimicrobial-resistance/interagency-coordination-gr....
    1. Cox M.J., Loman N., Bogaert D., O’Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1(1):e11. - PMC - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Uyeki T.M., Bernstein H.H., Bradley J.S., Englund J.A., File T.M., Fry A.M. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;68(6):e1–47. - PMC - PubMed
    1. Covid-19 guidelines of the China National Health Commission [Internet]. Available from: https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diag....

Substances